Nuplazid 34 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DX25F6XNL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,459
Award facts
- Contract value 100% obligated
- $3,458.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,458.51 on July 14, 2025, for the supply of Nuplazid 34 mg capsules (30-count packages) under contract 4568809623. The award utilizes firm fixed-price pricing with no set-aside designation and is scheduled for completion by August 4, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.999 billion and valid through November 2026, which enables the issuance of delivery orders for comprehensive pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
The funding originates from the Medical Supply Chain division within the Defense Department, reflecting the military healthcare system's ongoing pharmaceutical supply requirements. Nuplazid (pimavanserin) is an atypical antipsychotic medication used in treating Parkinson's disease psychosis, consistent with DMS Pharmaceutical Group's established portfolio of specialized pharmaceutical products delivered to federal healthcare systems. The contractor's selection demonstrates its capability as a critical supplier within the federal pharmaceutical distribution network, leveraging its established relationship with the Defense Logistics Agency to fulfill specific medical supply needs across military health installations.
Quick answers
Who was awarded contract SPE2DX25F6XNL?
SPE2DX25F6XNL was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 14, 2025.
How much is contract SPE2DX25F6XNL worth?
The government has obligated $3,459 on SPE2DX25F6XNL.
Is contract SPE2DX25F6XNL an order under another contract?
Yes. SPE2DX25F6XNL is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XNL competed?
The extent of competition for SPE2DX25F6XNL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award